BOSTON--(BUSINESS WIRE)--T1D Exchange today announced the launch of a population health surveillance study of individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted ...

BOSTON and INDIANAPOLIS, April 9, 2014 /PRNewswire/ -- T1D Exchange and Eli Lilly and Company (NYSE: LLY) announced today they have entered into a research collaboration that will enable both ...

T1D Exchange, a Boston-based nonprofit that promotes Type 1 diabetes research, has announced the launch of an open online patient data registry. By collecting information from children and adults with ...

BOSTON--(BUSINESS WIRE)--T1D Exchange today named David Walton as Chief Executive Officer. Having served as interim CEO since April 2019, Mr. Walton will assume permanent responsibilities for leading ...

Studies underscore advances in screening, mental health, health equity, and early intervention in diabetes care. New study examines benefits of continuous glucose monitoring (CGM) in people with type ...

BOSTON, Nov. 1, 2013 /PRNewswire/ -- T1D Exchange, the first program of the new nonprofit organization Unitio, has received a $2.8 million research grant from JDRF to study the use of metformin--a ...

Eli Lilly has entered into a multi-year research collaboration with T1D Exchange, the first programme launched by US-based non-profit Unitio, to gather real-world insights into the experiences of ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The first-ever Diabetes Innovation Challenge launched today ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen by an independent group of researchers. The Nature Index provides absolute Count of ...

The positions in the table below reflect the T1D Exchange's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...

BOSTON, June 11, 2025 /PRNewswire/ -- T1D Exchange, a nonprofit organization that drives meaningful research and improvement in care and outcomes in type 1 diabetes (T1D) and type 2 diabetes (T2D), ...